Dow Up0.44% Nasdaq Up0.05%

Sucampo Pharmaceuticals, Inc. (SCMP)

-NasdaqGM
6.81 Down 0.17(2.44%) 2:05PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 24,069   22,161   24,490   21,162  
Cost of Revenue3,672  3,517  2,945  6,267  
Gross Profit 20,397   18,644   21,545   14,895  
Operating Expenses
Research Development4,252  5,135  6,996  4,474  
Selling General and Administrative12,210  10,904  11,870  11,465  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 3,935   2,605   2,679   (1,044)
Income from Continuing Operations
Total Other Income/Expenses Net(30)(266)1,206  (223)
Earnings Before Interest And Taxes3,905  2,339  3,885  (1,267)
Interest Expense392  400  445  461  
Income Before Tax3,513  1,939  3,440  (1,728)
Income Tax Expense1,822  1,264  1,287  (2,825)
Minority Interest -   -   -   -  
Net Income From Continuing Ops1,691  675  2,153  1,097  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 1,691   675   2,153   1,097  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 1,691   675   2,153   1,097  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.